Tuesday, 30 June 2015
THE EAGLES WATCH JUST GOT A NEW UPGRADE!
For all our noble visitors on Eagles Watch, I am happy to inform you of the latest upgrade that just took place on the blog. Eagles Watch has now got a lot more user friendly than ever before. We promise to serve you better in as the day goes by.
Tuesday, 23 June 2015
THE BIRTH OF MALARIA-PROOF VACCINE; VERY SOON MALARIA INFECTION WOULD BE IMPOSSIBLE
INTRODUCING SANARIA® PfSPZ vaccine:
In the first half of the 20th century there were first attempts to protect people from malaria. At the beginning Pasteur´s approach of developing bacterial vaccines was used as a big hope in eradication of this fatal disease. But inactivated malaria sporozoites (by formalin) were ineffective in inducing the protection.
Later, modern adjuvants and the possibility of preparing of single parasite proteins started another way to obtain malaria vaccine. Today, a vaccine called RTS,S based on coat protein of sporozoites of the Plasmodium falciparum is the most advanced subunit vaccine and is in the phase III clinical trials. It protects about 50% of subjects infected by controlled human malaria infection (CHMI) after 2 – 3 weeks and about 23% at 5 months after last immunization.[4] In large III phase trial in Africa RTS,S/AS01 reduced acquired malaria over a 12 months period by 31,3% and 36,6%.
SANARIA® PfSPZ vaccine is a preventative malaria
In the first half of the 20th century there were first attempts to protect people from malaria. At the beginning Pasteur´s approach of developing bacterial vaccines was used as a big hope in eradication of this fatal disease. But inactivated malaria sporozoites (by formalin) were ineffective in inducing the protection.
Later, modern adjuvants and the possibility of preparing of single parasite proteins started another way to obtain malaria vaccine. Today, a vaccine called RTS,S based on coat protein of sporozoites of the Plasmodium falciparum is the most advanced subunit vaccine and is in the phase III clinical trials. It protects about 50% of subjects infected by controlled human malaria infection (CHMI) after 2 – 3 weeks and about 23% at 5 months after last immunization.[4] In large III phase trial in Africa RTS,S/AS01 reduced acquired malaria over a 12 months period by 31,3% and 36,6%.
SANARIA® PfSPZ vaccine is a preventative malaria
Subscribe to:
Posts (Atom)
Featured Post
AMAZINIG HEALTH BENEFITS OF BITTER LEAF YOU NEVER KNOW
fresh African Bitter leaf plant. Bitter leaf is a tropical plant found in different part of the world ...
-
Google is reportedly developing a smart contact lens that will measure a wearer's glucose levels by testing their tears.
-
Sweet Potatoes. Jpg Sweet Potatoes are an incredibly nutritious food that are packed with antioxidants like beta carotene, vitamins C... -
Researchers have revealed that tobacco smoking and inhalation produces a life of slavery, as well as a host of chronic, debilitating ill...
